It is widely recognized that VEGF is a key mediator of angiogenesis and an effective biological target for patients with metastatic colorectal cancer, and its overexpression can accelerate tumor progression and metastatic spread of colorectal cancer [27,28]. Here, VEGFA is linked to colorectal cancer.